9-Methylguanine - CAS 5502-78-3
Catalog: |
BB028889 |
Product Name: |
9-Methylguanine |
CAS: |
5502-78-3 |
Synonyms: |
2-amino-9-methyl-1H-purin-6-one |
IUPAC Name: | 2-amino-9-methyl-1H-purin-6-one |
Description: | 9-Methylguanine (CAS# 5502-78-3) is a useful research chemical. |
Molecular Weight: | 165.15 |
Molecular Formula: | C6H7N5O |
Canonical SMILES: | CN1C=NC2=C1N=C(NC2=O)N |
InChI: | InChI=1S/C6H7N5O/c1-11-2-8-3-4(11)9-6(7)10-5(3)12/h2H,1H3,(H3,7,9,10,12) |
InChI Key: | UUWJNBOCAPUTBK-UHFFFAOYSA-N |
Boiling Point: | 503.9 °C at 760 mmHg |
Density: | 1.83 g/cm3 |
MDL: | MFCD00037988 |
LogP: | -0.18000 |
Publication Number | Title | Priority Date |
US-11028379-B1 | FCE mRNA capping enzyme compositions, methods and kits | 20210127 |
WO-2021209419-A1 | Bi- and monocyclic nucleoside analogs for treatment of hepatitis e | 20200414 |
WO-2021209425-A1 | Alkynyl nucleoside analogs for treatment of hepatitis e | 20200414 |
WO-2021207641-A1 | Antisense oligonucleotide (aso) molecules and uses thereof for coronavirus diseases | 20200410 |
WO-2021124249-A1 | Use of hyaluronic acid derivatives in the regeneration of bone and cartilage tissues | 20191220 |
PMID | Publication Date | Title | Journal |
22946514 | 20121015 | Theoretical studies of chemical reactivity of metabolically activated forms of aromatic amines toward DNA | Chemical research in toxicology |
22903512 | 20121014 | Factors that influence the antiproliferative activity of half sandwich Ru(II)-[9]aneS3 coordination compounds: activation kinetics and interaction with guanine derivatives | Dalton transactions (Cambridge, England : 2003) |
22380407 | 20121001 | A study of clinico-pathological parameters and O⁶-methylguanine DNA methyltransferase (MGMT) promoter methylation status in the prognostication of gliosarcoma | Neuropathology : official journal of the Japanese Society of Neuropathology |
22549111 | 20120907 | MGMT inhibition restores ERα functional sensitivity to antiestrogen therapy | Molecular medicine (Cambridge, Mass.) |
22911013 | 20120901 | New treatment options with cytotoxic agents in neuroendocrine tumours | Targeted oncology |
Complexity: | 250 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 165.06505986 |
Formal Charge: | 0 |
Heavy Atom Count: | 12 |
Hydrogen Bond Acceptor Count: | 3 |
Hydrogen Bond Donor Count: | 2 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 165.06505986 |
Rotatable Bond Count: | 0 |
Topological Polar Surface Area: | 85.3 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | -0.9 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Purines
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS